Evidence map›Paper›PMID 24440384›Full record

ReviewExperimental gerontology2014

CD4 T cell defects in the aged: causes, consequences and strategies to circumvent.

Wenliang Zhang, Vinayak Brahmakshatriya, Susan L Swain

Abstract readReview
In one paragraph

Review in Experimental gerontology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. IgDAging cell · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. DUSP6 mediates T cell receptor-engaged glycolysis and restrains TProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Innate immune responses in the ageing lung.Clinical and experimental immunology · 2017
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wenliang ZhangDepartment of Pathology, University of Massachusetts Medical School, USA.
Vinayak BrahmakshatriyaDepartment of Pathology, University of Massachusetts Medical School, USA.
Susan L SwainDepartment of Pathology, University of Massachusetts Medical School, USA. Electronic address: Susan.Swain@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

MOLECULAR BIOLOGY COREP01AG021600 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HAYNES, LAURA · 2003 to 2016
$24.4M
Impact of aging on naive CD4 T cell functionR37AG025805 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2005 to 2014
$3.9M
NIA NIH HHS P01 AG021600NIA NIH HHS R37 AG025805
6 · The paper itself

Abstract

Aging leads to reduced immunity, especially adaptive responses. A key deficiency is the poor ability to mount robust antibody response. Although intrinsic alterations in B cells with age are in part responsible, impaired CD4 T cell help makes a major contribution to the poor antibody response. Other CD4 effector responses and memory generation are also impaired. We find delayed and reduced development of CD4 T follicular help (Tfh) cells in aged mice in response to influenza infection with reduction of long-lived plasma cells. When we examine CD4 subsets we also find a shift towards Th1 and cytotoxic CD4 (ThCTL) responses. We summarize strategies to circumvent the CD4 T cell defect in aged, including adjuvants and proinflammatory cytokines. We find that we can strongly enhance responses of aged naïve CD4 T cells by using Toll-like receptor (TLR) activated dendritic cells (DC) as APC in vivo and that this leads to improved germinal center B cells and IgG antibody responses. The enhanced response of aged naïve CD4 T cells is dependent on IL-6 produced by the DC.

Indexed as

Adaptive ImmunityAdjuvants, ImmunologicAgedAgingAnimalsB-LymphocytesCD4-Positive T-LymphocytesCell CommunicationCytokinesHumansInterleukin-6MiceT-Lymphocytes, Helper-InducerT-Lymphocyte SubsetsAdjuvants, ImmunologicCytokinesInterleukin-6Ab productionAgingCD4 T cell helpCD4 T cellsIL-6

Identifiers

PMID24440384
PMCPMC3989398
OpenAlexW2023718350

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.